death, consequence of an excessive inflammatory process triggered by SARS-CoV-2
infection. The diffuse inflammation leads to endothelium dysfunction in pulmonary blood
vessels, uncoupling eNOS activity, lowering NO production, causing pulmonary
physiological alterations and coagulopathy. On the other hand, iNOS activity is increased,
which may be advantageous for host defense, once NO plays antiviral effects. However …